Pseudo-Progression and the Neutrophil-To-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors: A Case–Control Study

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s228138